- (a) The APN seeking to maintain prescriptive authority shall attest, on forms provided by the board, to completing at least five contact hours of continuing education in pharmacotherapeutics within the preceding biennium.
- (b) The continuing education requirement in subsection (a) of this section, shall be in addition to continuing education required under §217.15 of this title (relating to Continuing Education).
Source Note:The provisions of this §222.3 adopted to be effective December 20, 1995, 20 TexReg 10268.